Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial

Innovative Therapies for Children with Cancer (ITCC) Consortium, European Association for Neuroblastoma Research (SIOPEN)

Research output: Contribution to journal › Article › peer-review

14 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences